Lenvatinib en Cáncer Diferenciado de Tiroides: Respuestas tras la Refractariedad al Radioyodo - page 18

Degree of response

is related with higher benefit in PFS

Presented by: Martin Schlumberger, MD

Robinson B, et al.

J Clin Endocrinol Metab

2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27